Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension - Wikidata - thesis-toulmin - TriplyDB

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

http://www.wikidata.org/entity/Q33898213

about

DNA Damage and Pulmonary Hypertension Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY-8040 in a Pulmonary Arterial Hypertension Rat Model Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB The cancer theory of pulmonary arterial hypertension.Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.Role of prostacyclin in pulmonary hypertension.Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury High-mobility group box-1 induces vascular remodelling processes via c-Jun activation Progress in the understanding and management of pulmonary arterial hypertension.The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.Transcriptome Analysis and Gene Identification in the Pulmonary Artery of Broilers with Ascites Syndrome.Update in Pulmonary Vascular Diseases 2014.Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension.Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients.Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms.Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.Inhibitory effect of Bailing capsule on hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.Pulmonary arterial hypertension secondary to adult-onset Still's disease: Response to cyclosporine and sildenafil over 15 years of follow-up.Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.Versican accumulates in vascular lesions in pulmonary arterial hypertension.Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension.Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension.Novel Targets of Drug Treatment for Pulmonary Hypertension.Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.Molecular pathogenesis and current pathology of pulmonary hypertension.Importance of kynurenine in pulmonary hypertension.BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population.Lung Circulation.

P2860

Q27005594-DD7A629E-CE7A-4167-8E44-DE73C80179FE Q27702090-73BC10EF-3C5A-46D8-B150-2B6BC04A7AD7 Q28546581-26C94F7B-4813-4DBB-8C0B-AA2566F111FF Q33783941-C9EA554F-DB99-4937-AE92-E9829C2F0D4F Q33788493-40BC1611-4370-40CA-9E66-16A8902619C4 Q33920050-E1259EAE-6009-43F5-A143-5C340F8C4A1C Q35165100-793606B5-CB37-4C72-A161-946735CA4BBC Q35555139-D1C0ED20-11E9-48E3-8F5F-73B2C972695C Q35571972-CD074940-F79B-413F-A823-C0D9E1EB2C0A Q35662646-FB8266F1-0FBB-45AA-A6F1-4ED5C9C02765 Q35665034-62C075F0-027E-4D2A-BF26-0817A72F256D Q35766693-EBC92B10-946F-4839-AFC3-D844E28DB5A7 Q35944064-4A129B0D-647D-4D91-9F43-917191C72B18 Q36044926-9A44939A-07BC-4171-8193-2F1FDED98656 Q36128639-2FE6CCDD-A052-4BE8-85FC-9DEA9B6AD4D3 Q36190169-4B54708C-DF44-4B4D-B24A-3D719DD39784 Q36382353-B551CA3A-D338-43A8-89FE-F62C9E79BA9A Q36439989-C6CEDB7C-BAD7-411F-9E5D-580254F0E28B Q36565424-DFD281EC-EAA2-484B-A06A-65CD07DEB120 Q36916730-00228332-90F3-411E-9E53-653EBF570244 Q36936599-3DAFF963-1C5C-4CEB-9475-B078FB9BDE93 Q37004101-81F731B3-7B93-4D45-8B15-F8AB827F80E1 Q37053491-5D6CD0B8-73F0-4403-A4F3-8BEE9C2AE1A3 Q37112304-DC113906-4B92-4E5D-9C05-604D6A841CCA Q37217507-1E775A98-4482-4B4A-B2A8-963520A6491D Q37223938-9B982BCF-42B8-43DB-AE01-D61A2EA1C946 Q37248333-E62EE66E-A261-4E68-A21D-79C6324041E4 Q37497182-A4DB7339-8B9C-4565-AAFF-56ACC1885912 Q37620501-C377DC4D-46BD-4E07-9B0C-11054A02D0A6 Q37642747-AAB093AE-4D54-41F6-B518-2AB34116822D Q38438856-7E5BD68A-76F7-486F-B2FF-2C1489DE8B69 Q38504399-8B4A65B5-604C-4FF4-9BDB-0C5B0972B808 Q38601788-5637285F-0F34-45E0-BCC5-4C9D1B429634 Q38676413-1AE1CC46-AA5B-4F3A-B849-3805FE939569 Q38680121-95A1A750-3481-4E05-84ED-4A19FE306D3E Q38732718-F72A26D7-DD84-4330-8BB1-799A9B0DD7BF Q38736112-051808FF-14B0-4046-84FB-7FFE8B7862D6 Q38779774-C9917DA7-0793-4DAD-95B4-EBAAAA9EB30C Q38797632-76505804-FE8E-4092-95E4-EB6517E731C8 Q38804579-85A1423A-1B3E-40B8-91AF-22837FDEF409

P2860

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

http://www.wikidata.org/entity/Q33898213

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@ast

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@en

type

label

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@ast

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@en

prefLabel

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@ast

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@en

P1433

Q33898213-1449F966-4C3A-435E-954B-829DDABE567C

P1476

Q33898213-0A100FA3-C80D-4688-8A0A-CC2C9F303529

P2093

Q33898213-1191D265-7BB3-442D-A9C0-BD097AEFC9F3

Q33898213-2716BE12-0651-4A89-B1E2-E5B82D6F545D

Q33898213-8A3B8EA5-97B8-4800-AF59-37184B885391

P2860

Q33898213-012DAF4B-72E0-498B-8DED-C9CCB52641F2

Q33898213-0229E96E-A425-421E-AF8A-31265DC4D803

Q33898213-02512316-5D09-4A93-87F5-64DE17B998B7

Q33898213-025CAA69-B8AE-4E0D-A47D-8A3BD4DEC4FC

Q33898213-0418C735-F813-4CAB-8627-46DFE6AEB30B

Q33898213-04ED0049-0B08-4200-BADB-770C3AE72177

Q33898213-06475EB2-7B64-4C90-B8E2-DB53E767588C

Q33898213-06E743AF-5C23-477D-A96A-F7484B918DC1

Q33898213-07B3F0B3-1D3F-4577-BC75-E9C71F6D2F67

Q33898213-08003386-462C-49C9-AEA0-1CE35089D6D0

P304

Q33898213-A7CB334A-F5D1-4E16-9221-0EFD4B4FB197

P31

Q33898213-B3CDD11E-2FF3-4990-B3BD-590616ABA757

P356

Q33898213-25764B78-E1FD-4C8C-B037-EF0FD6934BAD

P433

Q33898213-70E3D69A-170F-4581-B0A7-64A45D48FBE7

P478

Q33898213-4F428567-6D22-4968-BFDE-05382CFCADA5

P50

Q33898213-59D4156F-3F1B-4692-96B6-F0A724610164

P577

Q33898213-46E40093-BF8D-448C-9D42-BDD06D691B87

P5875

Q33898213-EE3972EE-1345-4DE7-A9D4-BB89275A9CCC

P698

Q33898213-D6C6E2E7-11A8-4497-A1EC-AAB281C3EC70

P921

Q33898213-8CCA87D3-68BE-446E-8432-7D1BD3ED2717

P932

Q33898213-C780FC49-5889-4941-BF74-A74BF68CC623

P356

CIRCRESAHA.113.301141

P1433

Circulation Research

P1476

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

@en

P2093

Christophe Guignabert

http://www.w3.org/2001/XMLSchema#string

Mark R Nicolls

http://www.w3.org/2001/XMLSchema#string

Marlene Rabinovitch

http://www.w3.org/2001/XMLSchema#string

P2860

MIF signal transduction initiated by binding to CD74

Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation

Inflammation, stress, and diabetes

Obesity is associated with macrophage accumulation in adipose tissue

CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension

Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice

P304

165-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.113.301141

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263290629

http://www.w3.org/2001/XMLSchema#string

P698

24951765

http://www.w3.org/2001/XMLSchema#string

P921

P932

4097142

http://www.w3.org/2001/XMLSchema#string